Advancements in Translational Science for Pain Management in Cancer Care Symposium

The Advancements in Translational Science for Pain Management in Cancer Care Symposium serves as a catalyst for collaborative innovation in pain sciences, bringing together experts from diverse backgrounds to address the complex challenges of cancer-related pain. This unique platform fosters interdisciplinary discussions on cutting-edge research, bridging the gap between basic science discoveries and clinical applications.

1. Design interdisciplinary strategies to train the next generation of international thought leaders in pain research and clinical practice.
2. Describe key components of effective training programs for developing international leaders in pain research and clinical care.
3. Discuss emerging technologies and non-pharmacological interventions for effective pain control in cancer patients and survivors.
4. Synthesize translational research findings to advance personalized pain management solutions across the cancer care continuum.

The Advancements in Translational Science for Pain Management in Cancer Care Symposium, will take place in the Zayed Building (6565 MD Anderson Blvd), Floor 2, conference center. The symposium will begin at 3:00 PM on Thursday, May 8 with a Poster Session and Welcome Reception. The General Session will take place on Friday, May 9, and conclude at 4:30 PM.

Thur., May 8
Poster Session + Welcome Reception
2:15 PM - 5:00 PM

Fri., May 9
General Session
8:00 AM - 4:30 PM

Call for Abstracts
Faculty, researchers, clinicians, and trainees are invited to submit abstracts for presentation at The Advancements in Translational Science for Pain Management in Cancer Care Symposium. We welcome original research related to pain management in cancer care, including but not limited to:

•          Basic science and translational research in cancer pain

•          Novel assessment tools for pain in cancer patients

•          Innovative treatments for cancer-related pain

•           Quality improvement initiatives in cancer pain management

•            Interdisciplinary approaches to pain care in oncology

Previously presented or published work related to cancer pain management will be considered.

Abstract Submission Deadline: April 3, 2025 @ 11:59 PM CST

More abstract information below.

Registration Fees

Advanced registration is encouraged as space is limited.  Please see registration section below for applicable fees. 

We accept the following forms of payment:

  •Credit Cards (MasterCard, VISA, and American Express)
  •Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form. 

Telephone registrations are not accepted.

Refund/Cancellation Policy
The registration fee, minus a $25 administration-handling fee, is refundable if a written request is received on or before April 10, 2024. No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information or Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the review course.

Abstract Specifications:

• Title (130 characters maximum, including spaces)

• List of Authors and Affiliations

• Abstract Text (250 words maximum), including:

  • Background

  • Hypothesis

  • Approach

  • Results

  • Conclusions

Submission Instructions:

• Email abstracts to [email protected]

• Registration is required for all abstract submissions.

Selected abstracts will be presented during the Poster Session on Thursday, May 8, 2025, from 3:00 PM to 5:00 PM in the Zayed Building, Floor 2 Conference Center.

Poster Specifications:

• Poster boards are 4 feet high by 6 feet wide

• Paper dimensions: 36 inches or 42 inches for height and up to 100 inches for width

• Include a 1-inch border

• No dark backgrounds

For questions regarding abstract submission, please contact [email protected]

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this live activity will award 5.50 Nursing Contact Hour(s)Credit Designation

The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

The University of Texas MD Anderson Cancer Center designates this application-based activity for 5.50 hours under UAN JA0004118-0000-25-001-L99-P. Credits will be provided to NABP CPE Monitor within 60 days after the activity completion. Learners must provide their NABP e-profile ID and Date of Birth in their MyCE Profile for credits to be reported to CPE Monitor.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Eric Gagneaux
Continuing Education Planner
MD Anderson Cancer Center

Activity Administrator

Non-Clinical Exception

Andrew J Shepherd, PhD
Assistant Professor
MD Anderson Cancer Center

Course Director, Faculty

Nothing to disclose

Kristine Crews, PharmD
Director of Scientific Research
St. Jude Children's Research Hospital

Faculty

Nothing to disclose

John T Farrar, MD, PhD
University of Pennsylvania

Faculty

Consulting Fee-Vertex Pharma|Consulting Fee-3Daughters |Consulting Fee-Scilex Holding Company

Chris Gibbons, PhD
Chief Applied Scientist
Oracle Health

Faculty

Nothing to disclose

Hongzhen Hu, PhD
Professor
Icahn School of Medicine at Mount Sinai

Faculty

Consulting Fee-Formation Bio and Almirall|Grant or research support-Triveni Bio

Nelda P. Itzep, MD
Fellow
MD Anderson

Faculty

Nothing to disclose

Khalil Ali Ahmad Kasm, PhD
Postdoctoral
UT MD Anderson Cancer Center

Faculty

Nothing to disclose

Patrick Dougherty, PhD
MD Anderson

Faculty, Other Planning Committee Member

Nothing to disclose

Josee Guindon, PhD
Associate Professor
Texas Tech University Health Sciences Center

Faculty, Other Planning Committee Member

Nothing to disclose

David J. Tweardy, MD
Division Head
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Advisor-Tvardi Therapeutics, Inc.

Marian Taylor, DNP
Continuing Education Specialist
MD Anderson Cancer Center

Nurse Planner

Nothing to disclose

Linda Abad, Physician Assistant
PA-C
MD Anderson

Other Planning Committee Member

Nothing to disclose

Salahadin Abdi, MD
Professor and Chair
Univ of TX, MD Anderson

Other Planning Committee Member

Nothing to disclose

Wendy A Allen, DNP
Associate Director
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Miracle Amaugwu, MBA, Sr. Administrative Assistant
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Juan Cata, MD
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Katie Delucia, Other, PA-C
Associate Director, Advanced Practice Providers
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Joylyn Mae Estrella, MSN
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Sorayah SB Gimenez, MSN, RN, CEN, OCN, CNL
Care Consultant Nurse
UT MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Nathan Goodwin, BS
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Poonam Goswami, PhD
Advanced Practice Registered Nurse
UT MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Peter M Grace, PhD
Chair Ad Interim
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Grant or research support-Biogen Inc. (Relationship has ended)|Grant or research support-HDAX (Relationship has ended)|Consulting Fee-Eurofarma|Stocks or stock options, excluding diversified mutual funds-ImmunoLogic

Carin A Hagberg, MD
SVP and Chief Academic Officer
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Grant or research support-Fisher & Paykel Healthcare|Grant or research support-Lucid Lane|Grant or research support-Karl Storz Endoscopy|Grant or research support-Teleflex|Grant or research support-Vyaire Medical Inc|Honoraria-Walters Kluwer Health

Carrie L Howard, MA, MBA, CCRP
Medicine Department Administrator
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Jitesh D Kawedia, PharmD, PhD
Clinical Pharmacy Specialist, Pharmacy Pharmacology Research
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Grant or research support-Saladax Biomedical|Consulting Fee-Saladax Biomedical

Tiambe Kuykendall, MSN
Nurse Manager
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Christopher J Lopez, MBA
Program Manager, Advanced Practice
MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Uzondu C. Osuagwu, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Brad J Phillips, DNP
Chief Nurse Anesthetist
The University of Texas MD Anderson Cancer Center

Other Planning Committee Member

Nothing to disclose

Vinay K. Puduvalli, MD
Professor and Chair
MD Anderson Cancer Center

Other Planning Committee Member

Paid consultant-Novocure|Paid consultant-Servier Pharmaceuticals|Paid consultant-Boehringer Ingelheim|Paid consultant-Telix Pharma|Paid consultant-NewBio (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Orbus Therapeutics|Stocks or stock options, excluding diversified mutual funds-Amarin (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Gilead|Stocks or stock options, excluding diversified mutual funds-Moderna|Grant or research support-Servier Pharmaceuticals|Grant or research support-Karyopharm Therapeutics|Grant or research support-InSightec|Grant or research support-Remedy Plan|Grant or research support-Bexion|Membership on Advisory Committees or Review Panels, Board Membership, etc.-InSightec

Silver Level

Vertex Pharmaceuticals